Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025)

Zhengye Biotechnology Holding has reported Raw Materials over the past 3 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Raw Materials rose 8.17% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 8.17% year-over-year, with the annual reading at $1.1 million for FY2025, 11.38% up from the prior year.
  • Raw Materials was $1.1 million for Q4 2025 at Zhengye Biotechnology Holding, up from $1.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $1.4 million in Q4 2023 and troughed at $1.0 million in Q4 2024.
  • The 3-year median for Raw Materials is $1.1 million (2025), against an average of $1.2 million.
  • Year-over-year, Raw Materials decreased 24.54% in 2024 and then increased 8.17% in 2025.
  • A 3-year view of Raw Materials shows it stood at $1.4 million in 2023, then decreased by 24.54% to $1.0 million in 2024, then rose by 8.17% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Raw Materials are $1.1 million (Q4 2025), $1.0 million (Q4 2024), and $1.4 million (Q4 2023).